Estimated 20% to 30% of patients on oral olanzapine are potential candidates for LAI. Absence of required monitoring expected to drive Olanzapine LAI usag ...
This week, we welcomed the PBAC decision to add ceftriaxone injection to the Prescriber Bag. This week, we welcomed the Pharmaceutical Benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback